Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy

Wajana Thaweerat

doi:10.1007/s12149-021-01712-6

Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy

Wajana Thaweerat

Department of Radiology

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	327-328
Number of pages	2
Journal	Annals of Nuclear Medicine
Volume	36
Issue number	3
DOIs	https://doi.org/10.1007/s12149-021-01712-6
Publication status	Published - Mar 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s12149-021-01712-6

Cite this

@article{c0ab8fa55ab74cf498fc09cdfbaf75c8,

title = "Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy",

author = "Wajana Thaweerat",

year = "2022",

month = mar,

doi = "10.1007/s12149-021-01712-6",

language = "English",

volume = "36",

pages = "327--328",

journal = "Annals of Nuclear Medicine",

issn = "0914-7187",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy

AU - Thaweerat, Wajana

PY - 2022/3

Y1 - 2022/3

UR - https://www.scopus.com/pages/publications/85123831337

U2 - 10.1007/s12149-021-01712-6

DO - 10.1007/s12149-021-01712-6

M3 - Letter

C2 - 35094260

AN - SCOPUS:85123831337

SN - 0914-7187

VL - 36

SP - 327

EP - 328

JO - Annals of Nuclear Medicine

JF - Annals of Nuclear Medicine

IS - 3

ER -

Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy

UN SDGs

Access to Document

Other files and links

Cite this